| Performance evaluation of a lateral flow assay for nasopharyngeal antigen detection for SARS‐CoV‐2 diagnosis M Peña‐Rodríguez, O Viera‐Segura, M García‐Chagollán, ... Journal of Clinical Laboratory Analysis 35 (5), e23745, 2021 | 26 | 2021 |
| Challenges in management of hepatitis A virus epidemiological transition in Mexico JL Trujillo-Ochoa, O Viera-Segura, NA Fierro Annals of Hepatology 18 (1), 14-22, 2019 | 23 | 2019 |
| Hepatitis E virus genotype 1 and hepatitis A virus dual infection in pediatric patients with a low socioeconomic status from Mexico M Realpe-Quintero, S Mirazo, O Viera-Segura, ED Copado-Villagrana, ... Intervirology 61 (3), 105-110, 2018 | 20 | 2018 |
| Prevalence of symptoms, comorbidities, and reinfections in individuals infected with wild-type SARS-CoV-2, Delta, or Omicron variants: a comparative study in western Mexico M Peña Rodríguez, J Hernández Bello, N Vega Magaña, O Viera Segura, ... Frontiers in public health 11, 1149795, 2023 | 18 | 2023 |
| First detection of hepatitis E virus genotype 3 as a common infectious agent in patients with chronic liver damage in Mexico O Viera-Segura, M Realpe-Quintero, A Panduro, S Roman, ... Annals of Hepatology 18 (4), 571-577, 2019 | 16 | 2019 |
| Cell culture isolation and whole genome characterization of hepatitis E virus strains from wild boars in Germany K Schilling-Loeffler, O Viera-Segura, VM Corman, J Schneider, ... Microorganisms 9 (11), 2302, 2021 | 10 | 2021 |
| Spatial and temporal distribution of hepatitis A virus and hepatitis E virus among children with acute hepatitis in mexico ED Copado-Villagrana, JY Anaya-Covarrubias, O Viera-Segura, ... Viral Immunology 34 (9), 653-657, 2021 | 8 | 2021 |
| Specific T-Cell immune response to SARS-CoV-2 spike protein over time in Naïve and SARS-CoV-2 previously infected subjects vaccinated with BTN162b2 N Vega-Magaña, JF Muñoz-Valle, M Peña-Rodríguez, O Viera-Segura, ... Vaccines 10 (7), 1117, 2022 | 7 | 2022 |
| Hepatitis E virus: still an enigma in Mexico M Realpe-Quintero, O Viera-Segura, NA Fierro Annals of Hepatology 17 (4), 544-546, 2018 | 7 | 2018 |
| A comprehensive descriptive epidemiological and clinical analysis of SARS-CoV-2 in West-Mexico during COVID-19 pandemic 2020 O Viera-Segura, N Vega-Magaña, M García-Chagollán, ... International Journal of Environmental Research and Public Health 18 (20), 10644, 2021 | 6 | 2021 |
| Evidence for increased inflammatory cytokine profile in hepatitis E virus-infected obese patients: Implications for chronic liver disease O Viera-Segura, A Panduro, JL Trujillo-Ochoa, E Copado-Villagrana, ... Viral Immunology 33 (9), 600-609, 2020 | 6 | 2020 |
| Tracing the history of hepatitis E virus infection in mexico: from the enigmatic genotype 2 to the current disease situation O Viera-Segura, A Calderón-Flores, JA Batún-Alfaro, NA Fierro Viruses 15 (9), 1911, 2023 | 4 | 2023 |
| Evaluation of Potential Furin Protease Inhibitory Properties of Pioglitazone, Rosiglitazone, and Pirfenidone: An In Silico Docking and Molecular Dynamics Simulation Approach AS Carranza-Aranda, CD Diaz-Palomera, E Lepe-Reynoso, A Santerre, ... Current Issues in Molecular Biology 46 (8), 8665-8684, 2024 | 1 | 2024 |
| Hepatitis E Virus Genotype 3 among Hemodialysis Patients in Mexico: First Identification of Chronic Infection ED Copado-Villagrana, IX Duarte-López, A Calderón-Flores, ... Pathogens 13 (7), 578, 2024 | 1 | 2024 |
| Beyond SARS-CoV-2: epidemiological surveillance of respiratory viruses in Jalisco, Mexico IM Pedroza-Uribe, N Vega Magaña, JF Muñoz-Valle, M Peña-Rodriguez, ... Frontiers in Public Health 11, 1292614, 2024 | 1 | 2024 |